Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia. Academic Article uri icon

Overview

publication date

  • March 8, 2021

Research

keywords

  • Antigens, CD19
  • Antineoplastic Combined Chemotherapy Protocols
  • Immunotherapy, Adoptive
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Identity

PubMed Central ID

  • PMC8423852

Scopus Document Identifier

  • 85102390744

Digital Object Identifier (DOI)

  • 10.1038/s41375-021-01196-3

PubMed ID

  • 33686196

Additional Document Info

volume

  • 35

issue

  • 11